Erwan Jouannot

Precision Medicine Lead @Sanofi

Paris, FR

EMAILS

[email protected]

MOBILE NUMBERS

+91 *********19

Reveal Contact Details

Signup · Get unlimited contacts

WORK HISTORY

Dec 2022 — Present

Precision Medicine Lead @Sanofi

View department →

Paris, FR

EDUCATION

2019 — 2021

Université Paris Dauphine - PSL

executive MBA

2001 — 2002

Pierre and Marie Curie University

Master's degree

2002 — 2005

Pierre and Marie Curie University

phD

SKILLS

Proactive in the Establishment of New CollaborationsPreclinical Molecular Imaging (Ultrasound Imaging, Pet, Μct, Bioluminescence)OncologyInternship Advisor (License and Master Students)Hardware Programming (C, C++) and Software Programming (Matlab, Labview)Life SciencesCellular Assays and HistologyMonoclonal Antibodies Radiolabeling for Pet ImagingOncologieRodent Tumor Model (S.c. and Orthotopic Model) Including Cell CultureProject Team Member for the Molecular Imaging UnitSecteur PharmaceutiqueMouse Anatomy, Blood Sampling, AutopsyAnimal ExperimentationSignal Analyzing and ProcessingAnimal ModelsPharmacology (Including Specific Pharmacology Reports for Ind Application)In VivoImagerie MédicaleMouse Handling Techniques and Injection Routes (I.v., I.p., S.c., P.o.)Translational ResearchPharmacokinetics, Pharmacodynamics (Experimentation and Modeling)Recherche Médicamenteuse

ABOUT ERWAN JOUANNOT

Sanofi R&D: Global Head of Bioimaging (France/US, 16 FTEs) Sept 2020-Dec 2022Served as global head of biomedical imaging with 2 teams in France and 1 in the US with 16 permanent teammates. Interdigitated with project teams of Therapeutic Areas to support research portfolio with imaging biomarkers (>50 projects/year). Monitored performances of teams with metrics to accelerate top priority projects. Spearheaded major business initiatives to modernize imaging capabilities with external collaborations (CEA, Stanford, MGH, IMI consortium). Participated to due diligence to acquire Tidal Therapeutics (innovative mRNA-based research platform) and developed new methodologies to characterize mRNA delivery formulations for pharma and vaccines. Developed imaging digitalization (data management, image analysis automation, data capture) with internal and external digital teams (work presented at VIVATECH 2022).Sanofi R&D: Head of Nuclear Imaging France (France, 5 FTEs) 20••••20Implemented new nuclear biomarkers to increase internal capabilities to perform target engagement (metabolism, immune system imaging). Translated imaging biomarkers to clinical phase I trial (target engagement for Amcenestrant). Supervised the development of image analysis tools to accelerate workflow with start-up. Developed nuclear imaging for biologics as a routine (>100 drug candidates per year). Contributed to project transitions from M0 to M2 (support provided to 15 projects).Sanofi R&D: Expert in non-invasive Imaging on small animals (France) 20••••16Investigated novel imaging biomarkers in Immuno-oncology, oncology, diabetes, and neurosciences. Promoted and validated imaging biomarkers to support clinical trial (tumor perfusion for anti-vascular drugs in phase I). Explored local delivery of siRNA formulation with ultrasound techniques (internal research award).Stanford university: Visiting scholar (USA) 20••••14Developed sugar chemistry for bacterial infection imaging. Validated new imaging devices for clinical application (oncology). Facilitated projects execution in nuclear imaging including imaging companion diagnostic.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.